Parallax Volatility Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Parallax Volatility Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$1.54M	–	1525
2026 Q1	$1.54M	Sell	50,000 -19,300	-28%	-$565K	﹤0.01%	847
2025 Q4	$2.01M	Buy	69,300 +54,300	+362%	+$1.63M	﹤0.01%	948
2025 Q3	$417K	Sell	15,000 -43,400	-74%	-$1.1M	﹤0.01%	1279
2025 Q2	$1.42M	Buy	+58,400	New	+$1.28M	﹤0.01%	980
2025 Q1	–	Sell	-6,700	Closed	-$158K	–	1556
2024 Q4	$158K	Sell	6,700 -50,300	-88%	-$1.24M	﹤0.01%	1697
2024 Q3	$1.46M	Hold	57,000	–	–	﹤0.01%	1238
2024 Q2	$1.34M	Buy	57,000 +7,000	+14%	+$177K	﹤0.01%	1164
2024 Q1	$1.44M	Hold	50,000	–	–	﹤0.01%	1128
2023 Q4	$1.64M	Hold	50,000	–	–	﹤0.01%	1230
2023 Q3	$1.39M	Hold	50,000	–	–	﹤0.01%	1235
2023 Q2	$1.7M	Hold	50,000	–	–	﹤0.01%	1200
2023 Q1	$1.5M	Buy	50,000 +48,700	+3,746%	+$1.51M	﹤0.01%	1335
2022 Q4	$36.7K	Sell	1,300 -7,500	-85%	-$238K	﹤0.01%	2406
2022 Q3	$289K	Sell	8,800 -187,200	-96%	-$6.87M	﹤0.01%	2190
2022 Q2	$6.17M	Sell	196,000 -252,200	-56%	-$8.82M	0.01%	898
2022 Q1	$20.6M	Sell	448,200 -48,800	-10%	-$2.33M	0.01%	494
2021 Q4	$30.4M	Buy	497,000 +102,500	+26%	+$7.09M	0.03%	479
2021 Q3	$29.5M	Buy	394,500 +41,200	+12%	+$3.46M	0.02%	524
2021 Q2	$32.7M	Buy	353,300 +47,000	+15%	+$4M	0.03%	445
2021 Q1	$27.2M	Buy	+306,300	New	+$30.4M	0.02%	564

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Parallax Volatility Advisers's ARKG Position: Q2 2026 in Review

Parallax Volatility Advisers reduced its ARK Genomic Revolution ETF (ARKG) stake by 8.3% in Q2 2026, selling an estimated $50.6K and leaving 17,482 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Parallax Volatility Advisers first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.2M in Q1 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Parallax Volatility Advisers held 17,482 shares of ARK Genomic Revolution ETF worth $735K as of Q2 2026.
Parallax Volatility Advisers sold 1,589 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $50.6K.
ARK Genomic Revolution ETF made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1037 holding.
Parallax Volatility Advisers first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
Parallax Volatility Advisers's ARK Genomic Revolution ETF position peaked at $11.2M in Q1 2021.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.